{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T02:32:28Z","timestamp":1769308348678,"version":"3.49.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CSIR senior research fellowship","award":["CSIR No. 31\/002(0840)2010-EMR-1"],"award-info":[{"award-number":["CSIR No. 31\/002(0840)2010-EMR-1"]}]},{"name":"Neurodegenerative diseases: Causes and corrections","award":["BSC 00115"],"award-info":[{"award-number":["BSC 00115"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.neuint.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T17:15:42Z","timestamp":1439226942000},"page":"181-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits"],"prefix":"10.1016","volume":"89","author":[{"given":"Debashis","family":"Dutta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2118-7671","authenticated-orcid":false,"given":"Kochupurackal P.","family":"Mohanakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2015.08.005_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/rej.2009.1011","article-title":"NT-020, a natural therapeutic approach to optimize spatial memory performance and increase neural progenitor cell proliferation and decrease inflammation in the aged rat","volume":"13","author":"Acosta","year":"2010","journal-title":"Rejuv. Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1975.00490440064010","article-title":"Brain peroxidase and catalase in Parkinson disease","volume":"32","author":"Ambani","year":"1975","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuroscience.2012.05.039","article-title":"Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of parkinson's disease","volume":"218","author":"Anandhan","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2015.08.005_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2011.11.021","article-title":"Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP\/probenecid induced Parkinson's disease","volume":"1433","author":"Anandhan","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12640-012-9332-9","article-title":"Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP\/probenecid model of Parkinson's disease","volume":"23","author":"Anandhan","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib7","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/01.CCM.0000142661.73633.15","article-title":"Theaflavin, a black tea extract, is a novel anti-inflammatory compound","volume":"32","author":"Aneja","year":"2004","journal-title":"Crit. Care. Med."},{"key":"10.1016\/j.neuint.2015.08.005_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.09.010","article-title":"Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease","volume":"22","author":"Armentero","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2015.08.005_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/19393210.2013.831951","article-title":"Essential and toxic metals in tea (Camellia sinensis) imported and produced in Ethiopia","volume":"7","author":"Ashenef","year":"2013","journal-title":"Food. Addit. Contam. Part B Surveill."},{"key":"10.1016\/j.neuint.2015.08.005_bib10","doi-asserted-by":"crossref","first-page":"581256","DOI":"10.1155\/2014\/581256","article-title":"Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration","volume":"2014","author":"Ayton","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.neuint.2015.08.005_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2008.11.007","article-title":"Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis","volume":"1792","author":"Banerjee","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2015.08.005_bib12","first-page":"245","article-title":"Inflammatory response in Parkinsonism","volume":"73","author":"Barcia","year":"2009","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuint.2015.08.005_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuint.2015.08.005_bib14","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1353-8020(13)70009-9","article-title":"Genetics of Parkinson's disease \u2013 state of the art, 2013","volume":"20","author":"Bonifati","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuint.2015.08.005_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5214\/ans.0972.7531.2009.160406","article-title":"Long term L-DOPA treatment causes production of 6-OHDA in the mouse striatum: involvement of hydroxyl radical","volume":"16","author":"Borah","year":"2009","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.neuint.2015.08.005_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neuint.2009.11.008","article-title":"Denervated, but not innervated striatum of parkinsonian rats is sensitive to 6-hydroxydopamine production in\u00a0vivo following prolonged L-DOPA administration","volume":"56","author":"Borah","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2015.08.005_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2010.05.010","article-title":"Salicylic acid protects against chronic L-DOPA -induced 6-hydroxydopamine generation in experimental model of parkinsonism","volume":"1344","author":"Borah","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib18","first-page":"68","article-title":"Relationships among molecular genetics and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues","volume":"1792","author":"Borland","year":"2009","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.neuint.2015.08.005_bib19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1096\/fj.07-9677com","article-title":"Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease","volume":"22","author":"Bousquet","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.neuint.2015.08.005_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2125.1990.tb03738.x","article-title":"Determinants of gait in the elderly parkinsonian on maintenance levodopa\/carbidopa therapy","volume":"30","author":"Bowes","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuint.2015.08.005_bib21","doi-asserted-by":"crossref","first-page":"30490","DOI":"10.1155\/MI\/2006\/30490","article-title":"Theaflavin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-inflammatory effect and modulation of STAT-1","volume":"5","author":"Cai","year":"2006","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuint.2015.08.005_bib22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jnutbio.2014.02.012","article-title":"Epigallocatechin gallate (EGCG) attenuates infrasound-induced neuronal impairment by inhibiting microglia-mediated inflammation","volume":"25","author":"Cai","year":"2014","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.neuint.2015.08.005_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s007020200064","article-title":"Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems","volume":"109","author":"Carlsson","year":"2002","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuint.2015.08.005_bib24","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.bbamem.2012.05.019","article-title":"Polyphenolic compounds are novel protective agents against lipid membrane damage by \u03b1-synuclein aggregates in\u00a0vitro","volume":"1818","author":"Caruana","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2015.08.005_bib25","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/mds.23226","article-title":"Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: a systematic review","volume":"25","author":"Cereda","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2015.08.005_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.23618","article-title":"Quercetin improves the activity of the ubiquitin-proteasomal system in 150Q mutated huntingtin-expressing cells but exerts detrimental effects on neuronal survivability","author":"Chakraborty","year":"2015","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2005.12.073","article-title":"Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats","volume":"1075","author":"Chandra","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.neulet.2009.12.028","article-title":"A\u00a0pro-drug of the green tea polyphenol (\u2212)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine","volume":"469","author":"Chao","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2015.08.005_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nbd.2005.12.008","article-title":"Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"22","author":"Chaturvedi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2015.08.005_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuroscience.2014.12.003","article-title":"Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral a-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys","volume":"286","author":"Chen","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2015.08.005_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fncel.2015.00124","article-title":"Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases","volume":"9","author":"Chin-Chan","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2015.08.005_bib33","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.neuro.2008.03.004","article-title":"Protective effect of the green tea component, L -theanine on environmental toxins-induced neuronal cell death","volume":"29","author":"Cho","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2015.08.005_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-813X(02)00079-7","article-title":"Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate","volume":"23","author":"Choi","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2015.08.005_bib35","doi-asserted-by":"crossref","first-page":"e12333","DOI":"10.1371\/journal.pone.0012333","article-title":"Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice","volume":"5","author":"Clark","year":"2010","journal-title":"Plos One"},{"key":"10.1016\/j.neuint.2015.08.005_bib36","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.neuint.2015.08.005_bib37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nn941","article-title":"Neuroprotective and neurorestorative strategies for Parkinson's disease","author":"Dawson","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2015.08.005_bib38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuint.2015.08.005_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410350107","article-title":"Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease","volume":"35","author":"Dexter","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib40","first-page":"579","article-title":"In a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease","volume":"4","author":"Djamshidian","year":"2014","journal-title":"J.\u00a0Park. Dis."},{"key":"10.1016\/j.neuint.2015.08.005_bib41","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2015.08.005_bib42","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1212\/WNL.0b013e3182194bad","article-title":"Group patient visits for Parkinson disease: a randomized feasibility trial","volume":"76","author":"Dorsey","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2015.08.005_bib43","article-title":"Striatal transplantation of human dopaminergic neurons differentiated from induced pluripotent stem cells derived from umbilical cord blood using lentiviral reprogramming","author":"Effenberg","year":"2014","journal-title":"Cell. Transpl."},{"key":"10.1016\/j.neuint.2015.08.005_bib44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bjp.0707510","article-title":"Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission","volume":"153","author":"Exley","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2015.08.005_bib45","first-page":"279","article-title":"Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey","volume":"52","author":"Finberg","year":"1998","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuint.2015.08.005_bib46","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1089\/ars.2009.2654","article-title":"Cell-based therapies for Parkinson's disease: past, present, and future","volume":"11","author":"Fitzpatrick","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuint.2015.08.005_bib47","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.0b013e31824f7fc4","article-title":"Habitual intake of dietary flavonoids and risk of Parkinson disease","volume":"78","author":"Gao","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2015.08.005_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.wco.0000170951.08924.3d","article-title":"Genetics of Parkinson's disease","volume":"18","author":"Gasser","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib49","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1093\/hmg\/ddq419","article-title":"Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1\/parkin-dependent manner upon induction of mitophagy","volume":"19","author":"Gegg","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2015.08.005_bib50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2015.08.005_bib51","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jbspin.2010.09.018","article-title":"Vitamin D and inflammation","volume":"77","author":"Guillot","year":"2010","journal-title":"Jt. Bone. Spine"},{"key":"10.1016\/j.neuint.2015.08.005_bib52","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.biopsych.2007.04.020","article-title":"Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway","volume":"62","author":"Guo","year":"2007","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuint.2015.08.005_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-015-9228-9","article-title":"Efficient docosahexaenoic acid uptake by the brain from a structured phospholipid","author":"Hachem","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2015.08.005_bib54","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/jmg.38.10.680","article-title":"Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36","volume":"38","author":"Hampshire","year":"2001","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuint.2015.08.005_bib55","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/ijms11031082","article-title":"Tyrosinase-expressing neuronal cell line as in\u00a0vitro model of Parkinson's disease","volume":"11","author":"Hasegawa","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2015.08.005_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00002512-200522060-00002","article-title":"Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience","volume":"22","author":"Hauser","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neuint.2015.08.005_bib57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2125.2002.01654.x","article-title":"Entacapone improves the availability of L-DOPA in plasma by decreasing its peripheral metabolism independent of L-DOPA\/carbidopa dose","volume":"54","author":"Heikkinen","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuint.2015.08.005_bib58","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.47.3.636","article-title":"Diet and Parkinson's disease. I: a possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study","volume":"47","author":"Hellenbrand","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2015.08.005_bib59","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1017\/S1461145710001665","article-title":"Acute nicotine enhances strategy-based semantic processing in Parkinson's disease","volume":"14","author":"Holms","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuint.2015.08.005_bib60","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbapap.2008.09.026","article-title":"Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation?","volume":"1794","author":"Hong","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2015.08.005_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2012.03.022","article-title":"Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model","volume":"102","author":"Hsieh","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2015.08.005_bib62","doi-asserted-by":"crossref","DOI":"10.1021\/jf501640a","article-title":"A\u00a0well-refined in\u00a0vitro model derived from human embryonic stem cell for screening phytochemicals with midbrain dopaminergic differentiation-boosting potential for improving Parkinson's disease","volume":"62","author":"Hsieh","year":"2014","journal-title":"J.\u00a0Agric. Food. Chem."},{"key":"10.1016\/j.neuint.2015.08.005_bib63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.10481","article-title":"Neuroinflammatory processes in Parkinson's disease","volume":"53","author":"Hunot","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib64","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.freeradbiomed.2007.11.011","article-title":"Curcumin treatment alleviates the effects of glutathione depletion in\u00a0vitro and in\u00a0vivo: therapeutic implications for Parkinson's disease explained via in silico studies","volume":"44","author":"Jagatha","year":"2008","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2015.08.005_bib65","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbadis.2011.02.013","article-title":"Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease","volume":"1812","author":"Jana","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2015.08.005_bib66","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbrc.2014.07.081","article-title":"1,25-Dyhydroxyvitamin D3 attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy","volume":"451","author":"Jang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2015.08.005_bib67","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neuint.2015.08.005_bib68","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","article-title":"Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats","volume":"600","author":"Jin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2015.08.005_bib69","doi-asserted-by":"crossref","first-page":"e7100","DOI":"10.1371\/journal.pone.0007100","article-title":"Novel mitochondrial substrates of omi indicate a new regulatory role in neurodegenerative disorders","volume":"4","author":"Johnson","year":"2009","journal-title":"Plos One"},{"key":"10.1016\/j.neuint.2015.08.005_bib70","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1152\/jn.00997.2014","article-title":"Modulation of motor cortex neuronal activity and motor behavior during subthalamic nucleus stimulation in the normal primate","volume":"113","author":"Johnson","year":"2015","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuint.2015.08.005_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2008.02.011","article-title":"Smoking and tea consumption delay onset of Parkinson's disease","volume":"15","author":"Kandinov","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuint.2015.08.005_bib72","doi-asserted-by":"crossref","first-page":"e11951","DOI":"10.1371\/journal.pone.0011951","article-title":"Dual beneficial effects of (\u2212)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in\u00a0vitro and in\u00a0vivo studies","volume":"5","author":"Kang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2015.08.005_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.11.043","article-title":"Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration","volume":"1497","author":"Kang","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2013.01.032","article-title":"Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats","volume":"236","author":"Karuppagounder","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2015.08.005_bib75","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuint.2015.08.005_bib76","doi-asserted-by":"crossref","first-page":"008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuint.2015.08.005_bib77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuint.2014.09.008","article-title":"In aging, the vulnerability of rat brain mitochondria is enhanced due to reduced level of 2\u2032,3\u2032-cyclic nucleotide-3\u2032-phosphodiesterase (CNP) and subsequently increased permeability transition in brain mitochondria in old animals","volume":"80","author":"Krestinina","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2015.08.005_bib78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000007984","article-title":"Elevated plasma levels of homocysteine in Parkinson's disease","volume":"40","author":"Kuhn","year":"1998","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib79","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1089\/ars.2009.2489","article-title":"A\u00a0disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications to Parkinson's disease","volume":"11","author":"Lee","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuint.2015.08.005_bib80","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11064-007-9442-6","article-title":"The role of 3-O-methyldopa in the side effects of L-DOPA","volume":"33","author":"Lee","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib81","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/emm.2007.42","article-title":"Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine","volume":"39","author":"Lee","year":"2007","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuint.2015.08.005_bib82","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","article-title":"Green tea polyphenol (\u2212)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration","volume":"78","author":"Levites","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2015.08.005_bib83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0006-2952(01)00813-9","article-title":"Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures","volume":"63","author":"Levites","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2015.08.005_bib84","doi-asserted-by":"crossref","first-page":"923464","DOI":"10.1100\/2012\/923464","article-title":"A\u00a0meta-analysis of tea drinking and risk of Parkinson's disease","volume":"2012","author":"Li","year":"2012","journal-title":"Sci. World J."},{"key":"10.1016\/j.neuint.2015.08.005_bib85","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2015.08.005_bib86","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0161-813X(01)00032-8","article-title":"Astrogliosis in the adult and developing CNS: is there a role for proinflammatory cytokines?","volume":"22","author":"Little","year":"2001","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2015.08.005_bib87","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00702-010-0434-3","article-title":"Increased iron levels correlate with the selective nigral dopaminergic neurondegeneration in Parkinson's disease","volume":"118","author":"Lv","year":"2011","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuint.2015.08.005_bib88","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbr.2014.01.051","article-title":"Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions","volume":"264","author":"Machado-Filho","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1440-1681.2012.05673.x","article-title":"Potential role of green tea catechins in various disease therapies: progress and promise","volume":"39","author":"Mak","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuint.2015.08.005_bib90","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1385\/JMN:24:3:401","article-title":"Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green teapolyphenol (\u2212)-epigallocatechin-3-gallate","volume":"24","author":"Mandel","year":"2004","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuint.2015.08.005_bib91","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mnfr.200500156","article-title":"Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders","volume":"50","author":"Mandel","year":"2006","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib92","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1755-5949.2008.00060.x","article-title":"Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases","volume":"14","author":"Mandel","year":"2008","journal-title":"CNS. Neurosci. Ther."},{"key":"10.1016\/j.neuint.2015.08.005_bib93","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0773.1990.tb00756.x","article-title":"Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease","volume":"66","author":"Mannisto","year":"1990","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.neuint.2015.08.005_bib94","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0031-6997(24)01423-6","article-title":"Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology and clinical efficacy of the new selective COMT inhibitors","volume":"51","author":"Mannisto","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2015.08.005_bib95","doi-asserted-by":"crossref","first-page":"18171","DOI":"10.1073\/pnas.0405831102","article-title":"Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease","volume":"101","author":"Maswood","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2015.08.005_bib96","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuro.2014.11.006","article-title":"Unveiling the role of the pesticides paraquat and rotenone on \u03b1-synuclein fibrillation in\u00a0vitro","volume":"46","author":"Maturana","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2015.08.005_bib97","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson's disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuint.2015.08.005_bib98","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson's disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib99","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jns.2011.03.035","article-title":"Dietary intake of metals and risk of Parkinson's disease: a case-control study in Japan","volume":"306","author":"Miyake","year":"2011","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuint.2015.08.005_bib100","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0891-5849(02)01137-1","article-title":"Uptake and metabolism of epicatechin and its access to the brain after oral ingestion","volume":"33","author":"Mohsen","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2015.08.005_bib101","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1468-1331.2000.0070s1021.x","article-title":"Pramipexole in the treatment of advanced Parkinson's disease","volume":"7","author":"M\u00f6ller","year":"2000","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib102","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00315512","article-title":"Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease","volume":"45","author":"Myllyl\u00e4","year":"1993","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuint.2015.08.005_bib103","doi-asserted-by":"crossref","first-page":"14311","DOI":"10.1523\/JNEUROSCI.0499-12.2012","article-title":"1,3,5-AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson's disease","volume":"32","author":"Ng","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2015.08.005_bib104","first-page":"47","article-title":"Excitotoxicity: an overview","volume":"16","author":"Olney","year":"1990","journal-title":"Can. Dis. Wkly. Rep."},{"key":"10.1016\/j.neuint.2015.08.005_bib105","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archneur.63.9.1242","article-title":"Clinical heterogeneity of the LRRK2 G2019S mutation","volume":"63","author":"Papapetropoulos","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib107","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.expneurol.2013.12.021","article-title":"L-DOPA disrupts adenosineA(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in thestriatum of hemiparkinsonian rats: biochemical and behavioral studies","volume":"253","author":"Pinna","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib108","first-page":"114","article-title":"'Bad guys' among the antiparkinsonian drugs","volume":"21","author":"Pirtosek","year":"2009","journal-title":"Psychiatr. Danub"},{"key":"10.1016\/j.neuint.2015.08.005_bib109","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-\u03b3 agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2015.08.005_bib110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ajmg.a.30157","article-title":"Parkin mutation analysis in clinic patients with early-onset Parkinson disease","volume":"129","author":"Poorkaj","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuint.2015.08.005_bib111","first-page":"435","article-title":"A\u00a0meta-analysis of Parkinson's disease and exposure to pesticides","volume":"21","author":"Priyadarshi","year":"2000","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2015.08.005_bib112","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.21900","article-title":"Nicotine and Parkinson's disease: implications for therapy","volume":"23","author":"Quik","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2015.08.005_bib113","first-page":"94","article-title":"O-Methyldopa interferes with striatal utilization of levodopa","volume":"10","author":"Raches","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib114","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainresbull.2015.02.007","article-title":"N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: an investigation into the interaction of Parkin and Drp1 proteins","volume":"113","author":"Rahimmi","year":"2015","journal-title":"Brain. Res. Bull."},{"key":"10.1016\/j.neuint.2015.08.005_bib115","doi-asserted-by":"crossref","first-page":"e16746","DOI":"10.1371\/journal.pone.0016746","article-title":"Mutations in PINK1 and Parkin impair ubiquitination of mitofusins in human fibroblasts","volume":"6","author":"Rakovic","year":"2011","journal-title":"PLoS. One"},{"key":"10.1016\/j.neuint.2015.08.005_bib116","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000265946","article-title":"Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism","volume":"7","author":"Reznichenko","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuint.2015.08.005_bib117","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.redox.2014.04.007","article-title":"Thiol-reactivity of the fungicide maneb","volume":"2","author":"Roede","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.neuint.2015.08.005_bib118","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2005.04.051","article-title":"Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease","volume":"1049","author":"Saravanan","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib119","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0197-4580(03)00037-X","article-title":"Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease","volume":"25","author":"Simon","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2015.08.005_bib120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","article-title":"Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine","volume":"84","author":"Sindhu","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2015.08.005_bib121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2005.05.051","article-title":"Behavioural differences in a rotenone-induced hemiparkinsonian rat model developed following intra-nigral or median forebrain bundle infusion","volume":"1051","author":"Sindhu","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib122","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuint.2015.08.005_bib123","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2174\/1381612003399581","article-title":"Dopamine agonists in the treatment of Parkinson s disease past, present and future","volume":"6","author":"Sit","year":"2000","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.neuint.2015.08.005_bib124","doi-asserted-by":"crossref","first-page":"e0128510","DOI":"10.1371\/journal.pone.0128510","article-title":"Curcumin treatment improves motor behavior in \u03b1-synuclein transgenic mice","volume":"10","author":"Spinelli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2015.08.005_bib126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijdevneu.2009.01.003","article-title":"Mitochondrial alterations in aging rat brain: effective role of (\u2212)-epigallo catechin gallate","volume":"27","author":"Srividhya","year":"2009","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuint.2015.08.005_bib127","first-page":"940","article-title":"Neuroprotective potential of epigallo catechin-3-gallate in PC-12 cells","volume":"37","author":"Srividhya","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2015.08.005_bib128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/187152809789352249","article-title":"Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models","volume":"8","author":"Sugama","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.neuint.2015.08.005_bib129","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0306-4522(97)00660-X","article-title":"Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism","volume":"85","author":"Szir\u00e1ki","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2015.08.005_bib130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/jnc.13180","article-title":"Phenolic compounds prevent the oligomerization of \u03b1-synuclein and reduce synaptic toxicity","volume":"134","author":"Takahashi","year":"2015","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2015.08.005_bib131","first-page":"231","article-title":"Epidemiology of Parkinson's disease","volume":"18","author":"Tan","year":"2013","journal-title":"Neurol. Asia"},{"key":"10.1016\/j.neuint.2015.08.005_bib132","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1089\/ars.2009.2490","article-title":"Protein misfolding and aggregation in Parkinson's disease","volume":"11","author":"Tan","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuint.2015.08.005_bib133","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/jnnp.2006.104695","article-title":"Heterogeneity in male to female risk for Parkinson's disease","volume":"78","author":"Taylor","year":"2007","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neuint.2015.08.005_bib134","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1089\/ars.2009.2697","article-title":"Parkinson's disease: from molecular pathways in disease to therapeutic approaches","volume":"11","author":"Thomas","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuint.2015.08.005_bib135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00019052-200208000-00011","article-title":"Treatment options for Parkinson's disease","volume":"15","author":"Tintner","year":"2002","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuint.2015.08.005_bib136","doi-asserted-by":"crossref","first-page":"e72501","DOI":"10.1371\/journal.pone.0072501","article-title":"Engraftment of mouse embryonicstem cells differentiated by default leads to neuroprotection, behaviour revival and astrogliosis in parkinsonian rats","volume":"8","author":"Tripathy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2015.08.005_bib137","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-801022-8.00008-8","article-title":"Effects of the adenosine A2A receptor antagonist on cognitive dysfunction in Parkinson's disease","volume":"119","author":"Uchida","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuint.2015.08.005_bib138","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/322996","article-title":"Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36","volume":"69","author":"van Duijn","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuint.2015.08.005_bib139","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2008.12.021","article-title":"Reduced NADH coenzyme Q dehydrogenase activity in platelets of Parkinson's disease, but not Parkinson plus patients, from an Indian population","volume":"279","author":"Varghese","year":"2009","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuint.2015.08.005_bib140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1749-6632.2003.tb07544.x","article-title":"Gene and protein expression profiles of anti- and pro-apoptotic actions of dopamine, R-apomorphine, green tea polyphenol (\u2212)-epigallocatechine-3-gallate, and melatonin","volume":"993","author":"Weinreb","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2015.08.005_bib141","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for Parkinson's disease than women?","volume":"75","author":"Wooten","year":"2004","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neuint.2015.08.005_bib142","first-page":"538","article-title":"Adenosine and dopamine receptor interactions in striatum and caffeine-induced behavioral activation","volume":"57","author":"Xie","year":"2007","journal-title":"Comp. Med."},{"key":"10.1016\/j.neuint.2015.08.005_bib143","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bcmd.2010.07.014","article-title":"The familial Parkinson's disease gene DJ-1 (PARK7) is expressed in red cells and plays a role in protection against oxidative damage","volume":"45","author":"Xu","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.neuint.2015.08.005_bib144","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2015.08.005_bib145","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1089\/ars.2009.2624","article-title":"Cell death pathways in Parkinson's disease: role of mitochondria","volume":"11","author":"Yao","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuint.2015.08.005_bib146","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.freeradbiomed.2003.11.023","article-title":"Flavonoid permeability across an in situ model of the Blood\u2013brain barrier","volume":"36","author":"Youdim","year":"2004","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.neuint.2015.08.005_bib147","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2015.08.005_bib148","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/hmg\/ddr235","article-title":"The PINK1\/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons","volume":"20","author":"Yu","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2015.08.005_bib149","doi-asserted-by":"crossref","first-page":"254680","DOI":"10.1155\/2014\/254680","article-title":"Pu-erh tea extract induces the degradation of FET family proteins involved in the pathogenesis of amyotrophic lateral sclerosis","volume":"2014","author":"Yu","year":"2014","journal-title":"Biomed. Res. Int."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018615300334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018615300334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T23:17:21Z","timestamp":1748560641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018615300334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":147,"alternative-id":["S0197018615300334"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2015.08.005","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}